552303997	552303997	CD	B-NP	O
|	|	NN	I-NP	O
RLH	RLH	NN	I-NP	O
|	|	NN	I-NP	O
11079871	11079871	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
1547559	1547559	CD	B-NP	O
|	|	CC	I-NP	O
7/5/2006	7/5/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
fluid	fluid	NN	I-NP	I-protein
overload	overload	NN	I-NP	I-protein
2/2	2/2	CD	I-NP	I-protein
CKD	CKD	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/5/2006	7/5/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/28/2007	10/28/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O
GOYNES	GOYNES	NN	I-NP	O
,	,	,	O	O
DELMER	DELMER	NNP	B-NP	O
V	V	NNP	I-NP	O
867-74-83-8	867-74-83-8	CD	I-NP	O
Oklahoma	Oklahoma	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
7/9/07	7/9/07	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
STANFA	STANFA	NN	B-NP	O
,	,	,	O	O
TRUMAN	TRUMAN	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/9/07	7/9/07	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FENOFIBRATE	FENOFIBRATE	NNP	B-NP	O
,	,	,	I-NP	O
MICRONIZED	MICRONIZED	NNP	I-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
CIPROFLOXACIN	CIPROFLOXACIN	NN	B-NP	B-protein
500	500	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q24H	Q24H	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
10	10	CD	B-NP	I-protein
doses	dose	NNS	I-NP	I-protein
Food/Drug	Food/Drug	NNP	B-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Administer	Administer	NNP	I-NP	I-protein
iron	iron	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

PLAVIX	PLAVIX	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
ARANESP	ARANESP	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NON-ONCOLOGY	NON-ONCOLOGY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DARBEPOETIN	DARBEPOETIN	NNP	I-NP	O
ALFA	ALFA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
NON	NON	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
40	40	CD	B-NP	O
MCG	MCG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
TRICOR	TRICOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TRICOR	TRICOR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
145	145	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
November	November	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/30/06	4/30/06	CD	B-NP	O
by	by	IN	B-PP	O
BAXTOR	BAXTOR	NNP	B-NP	O
,	,	,	O	O
MYLES	MYLES	NNP	B-NP	O
P.	P.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
,	,	,	O	O
MICRONIZED	MICRONIZED	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	B-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
80	80	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QAM	QAM	NNP	I-NP	I-protein
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NNP	I-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
NOVOLOG	NOVOLOG	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3	3	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
November	November	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
or	or	CC	O	O
resume	resume	VB	B-VP	O
your	your	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
48	48	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
COMBIVENT	COMBIVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NNP	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Contraindicated	Contraindicated	NNP	I-NP	O
in	in	IN	B-PP	O
Patients	Patient	NNPS	B-NP	O
with	with	IN	B-PP	O
Peanut	Peanut	NNP	B-NP	O
,	,	,	O	O
Soya	Soya	NNP	B-NP	O
or	or	CC	O	O
Soyabean	Soyabean	NNP	B-NP	O
Allergy	Allergy	NNP	I-NP	O
AVAPRO	AVAPRO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IRBESARTAN	IRBESARTAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
LABETALOL	LABETALOL	NN	I-NP	O
HCL	HCL	NN	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NEPHROCAPS	NEPHROCAPS	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
NEPHRO-VIT	NEPHRO-VIT	NN	I-NP	O
RX	RX	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/30/06	4/30/06	CD	B-NP	O
by	by	IN	B-PP	O
AUMILLER	AUMILLER	NNP	B-NP	O
,	,	,	O	O
SAMMIE	SAMMIE	NNP	B-NP	O
I.	I.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
ADALAT	ADALAT	NN	B-NP	O
CC	CC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
NIFEDIPINE	NIFEDIPINE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
120	120	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
PCP	PCP	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Mangum	Mangum	NNP	I-NP	O
Tuesday	Tuesday	NNP	B-NP	O
7/18	7/18	CD	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	SYM	I-NP	O
30	30	CD	I-NP	O
PM	PM	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
fluid	fluid	VBD	B-VP	O
overload	overload	RB	B-NP	O
2/2	2/2	CD	I-NP	O
CKD	CKD	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CRI	CRI	NNP	I-NP	O
;	;	:	O	O
DM	DM	NN	B-NP	O
;	;	:	O	O
HTN	HTN	NN	B-NP	B-protein
;	;	:	O	O
obesity	obesity	NN	B-NP	O
;	;	:	O	O
smoking	smoke	VBG	B-VP	O
history	history	NN	B-NP	O
;	;	:	O	O
COPD	COPD	NN	B-NP	O
;	;	:	O	O
anemia	anemia	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
*****************	*****************	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
67	67	CD	B-NP	O
yo	yo	NN	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
2/2	2/2	CD	I-NP	O
DM	DM	NN	I-NP	O
nephropathy	nephropathy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	I-NP	O
COPD	COPD	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
on	on	IN	B-PP	O
5/3	5/3	CD	B-NP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
worsened	worsen	VBN	B-VP	O
by	by	IN	B-PP	O
exerction	exerction	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
PND	PND	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
note	note	NN	B-NP	O
increased	increase	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
abdominal	abdominal	JJ	B-NP	O
girth	girth	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reports	report	VBZ	B-VP	O
taking	take	VBG	I-VP	O
his	his	PRP$	B-NP	O
lasix	lasix	NN	I-NP	B-protein
80mg	80mg	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
daily	daily	RB	B-ADVP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
but	but	CC	B-PP	O
with	with	IN	B-PP	O
dietary	dietary	JJ	B-NP	O
indescretion	indescretion	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
salt	salt	NN	I-NP	O
intake	intake	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
lots	lot	NNS	I-NP	O
of	of	IN	B-PP	O
bacon	bacon	NN	B-NP	O
and	and	CC	O	O
canned	can	VBD	B-VP	O
soup	soup	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

******************	******************	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
CRI	CRI	NN	B-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
hx	hx	NN	B-NP	O
CVA	CVA	NN	I-NP	O
2002	2002	CD	I-NP	O
w/residual	w/residual	JJ	I-NP	O
L	L	NN	I-NP	O
arm	arm	NN	I-NP	O
numbness	numbness	NN	I-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
L	L	NN	I-NP	O
hip	hip	NN	I-NP	O
replacement	replacement	NN	I-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
combivent	combivent	VB	B-VP	O
BID	BID	NNP	B-NP	O
,	,	,	O	O
lantus	lantus	NN	B-NP	O
48U	48U	NN	I-NP	O
qam	qam	NN	I-NP	O
,	,	,	O	O
novolog	novolog	NN	B-NP	O
SS	SS	NN	I-NP	O
qAC	qAC	NN	I-NP	O
,	,	,	O	O
lasix	lasix	NN	B-NP	O
80mg	80mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
nifedipine	nifedipine	NN	B-NP	O
90mg	90mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
avapro	avapro	NN	B-NP	O
300mg	300mg	CD	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	I-NP	O
atenolol	atenolol	NN	I-NP	O
25mg	25mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
labetalol	labetalol	NN	B-NP	O
100mg	100mg	NN	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
75mg	75mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
81mg	81mg	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
40mg	40mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
tricor	tricor	NN	B-NP	O
145mg	145mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
nephrocaps	nephrocap	VBZ	B-VP	O
1	1	CD	B-NP	O
tab	tab	NN	I-NP	O
daily	daily	JJ	I-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	O
SH	SH	NN	I-NP	O
:	:	:	O	O
retired	retire	VBN	B-VP	O
SW	SW	NNP	B-NP	O
at	at	IN	B-PP	O
VHAHC	VHAHC	NNP	B-NP	O
,	,	,	O	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
wife	wife	NN	B-NP	O
,	,	,	O	O
daughter	daughter	NN	B-NP	O
,	,	,	O	O
granddaughter	granddaughter	NN	B-NP	O
HRB	HRB	NN	I-NP	O
:	:	:	O	O
quit	quit	VB	B-VP	O
tobacco	tobacco	NN	B-NP	O
25	25	CD	B-NP	O
years	year	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
etoch	etoch	NN	I-NP	O
FH	FH	NN	I-NP	O
:	:	:	O	O
father	father	NN	B-NP	O
with	with	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
and	and	CC	I-NP	O
MI	MI	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
65	65	CD	I-NP	O
*********************	*********************	SYM	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
97.1	97.1	CD	B-NP	O
,	,	,	I-NP	O
60	60	CD	I-NP	O
,	,	,	I-NP	O
122/60	122/60	CD	I-NP	O
,	,	,	I-NP	O
24	24	CD	I-NP	O
,	,	,	I-NP	O
97	97	CD	I-NP	O
%	%	NN	I-NP	O
4L	4L	NN	I-NP	O
NC	NC	NN	I-NP	O
,	,	,	O	O
wt	wt	NN	B-NP	O
262lbs	262lb	VBZ	B-VP	O
Well	Well	NNP	B-NP	O
appearing	appear	VBG	B-VP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
,	,	,	O	O
distant	distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
crackles	crackle	NNS	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
in	in	IN	B-PP	O
lower	low	JJR	B-NP	O
1/3	1/3	CD	I-NP	O
of	of	IN	B-PP	O
lungs	lung	NNS	B-NP	O
,	,	,	O	O
+	+	SYM	O	O
BS	BS	NNP	B-NP	O
,	,	,	O	O
obese	obese	JJ	B-NP	O
distended	distended	JJ	I-NP	O
abdomen	abdoman	NNS	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
knees	knee	NNS	B-NP	O
*********************	*********************	SYM	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
98.8	98.8	CD	B-NP	O
,	,	,	I-NP	O
65	65	CD	I-NP	O
,	,	,	I-NP	O
130/60	130/60	CD	I-NP	O
,	,	,	I-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
94RA	94RA	NN	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
241lb	241lb	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
peripheral	peripheral	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
ascultation	ascultation	NN	B-NP	O
.	.	.	O	O

*********************	*********************	SYM	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
admit	admit	VB	B-VP	O
labs	lab	NNS	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
K	K	NN	B-NP	B-protein
5.3	5.3	NN	I-NP	I-protein
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
92	92	CD	I-NP	I-DNA
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
3.8	3.8	CD	I-NP	O
,	,	,	O	O
Hct	Hct	NN	B-NP	B-protein
27.4	27.4	CD	I-NP	I-protein
,	,	,	O	O
WBC	WBC	NNP	B-NP	B-cell_line
8.8	8.8	CD	I-NP	I-cell_line
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
HbA1C	HbA1C	NN	B-NP	O
6.3	6.3	CD	I-NP	O
.	.	.	O	O

WBC	WBC	NN	B-NP	O
peak	peak	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Hct	Hct	NN	B-NP	O
nadir	nadir	NN	I-NP	O
26	26	CD	I-NP	O
.	.	.	O	O

BUN/Cr	BUN/Cr	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

D/C	D/C	NN	B-NP	O
K	K	NN	I-NP	O
4.5	4.5	CD	I-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
pending	pending	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-DNA
60	60	CD	I-NP	I-DNA
,	,	,	O	O
RBBB	RBBB	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	I-NP	O
old	old	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
LAD	LAD	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
old	old	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
CXR	CXR	NN	I-NP	O
:	:	:	O	O
low	low	JJ	B-NP	O
lung	lung	NN	I-NP	O
volumes	volume	NNS	I-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
congestion	congestion	NN	I-NP	O
ECHO	ECHO	NN	I-NP	O
:	:	:	O	O
LVH	LVH	NN	B-NP	O
,	,	,	O	O
LVEF	LVEF	NN	B-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
RV	RV	NN	B-NP	O
mild	mild	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
valvular	valvular	JJ	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
UCX	UCX	NN	I-NP	O
:	:	:	O	O
100K	100K	NN	B-NP	O
pansensitive	pansensitive	JJ	I-NP	O
Ecoli	Ecoli	NNP	I-NP	O
**********************	**********************	SYM	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
67M	67M	NN	I-NP	O
with	with	IN	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
from	from	IN	B-PP	O
CKD/dietary	CKD/dietary	JJ	B-NP	O
indiscretion	indiscretion	NN	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
SOB	SOB	NN	I-NP	O
:	:	:	O	O
felt	felt	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
from	from	IN	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
as	as	IN	B-SBAR	O
opposed	oppose	VBN	B-VP	O
to	to	TO	B-PP	O
COPD	COPD	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
or	or	CC	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

Ruled	Rule	VBN	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

Diuresed	Diurese	VBN	B-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
lasix	lasix	CD	I-NP	O
to	to	TO	B-PP	O
dry	dry	JJ	B-NP	O
weight	weight	NN	I-NP	O
241lb	241lb	NN	I-NP	O
then	then	RB	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
PO	PO	NN	B-NP	O
lasix	lasix	CD	I-NP	O
prior	prior	JJ	I-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CARDS	CARDS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
P	P	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
BP	BP	NN	B-NP	O
goal	goal	NN	I-NP	O
<	<	SYM	B-NP	O
130	130	CD	B-NP	O
given	give	VBN	I-NP	O
CKD	CKD	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
.	.	.	O	O

Unclear	Unclear	JJ	B-ADJP	O
why	why	WRB	B-ADVP	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
BB	BB	NN	I-NP	O
so	so	RB	B-ADVP	O
stopped	stop	VBD	B-VP	O
atenolol	atenolol	NN	B-NP	O
and	and	CC	O	O
titrated	titrate	VBD	B-VP	O
up	up	RP	B-PRT	O
labetalol	labetalol	NN	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
titrated	titrate	VBN	B-VP	O
up	up	RP	B-PRT	O
nifedipine	nifedipine	NN	B-NP	O
and	and	CC	O	O
added	add	VBD	B-VP	O
HCTZ	HCTZ	NN	B-NP	B-protein
to	to	TO	B-VP	O
get	get	VB	I-VP	O
at	at	IN	B-PP	O
BP	BP	NN	B-NP	O
goal	goal	NN	I-NP	O
.	.	.	O	O

Diuresed	Diurese	VBN	B-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
lasix	lasix	CD	I-NP	O
as	as	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
CARDS	CARDS	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
I	I	PRP	B-NP	O
-RRB-	-RRB-	VBP	B-VP	O
:	:	:	O	O
ruled	rule	VBN	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Maintained	Maintain	VBN	B-VP	O
on	on	IN	B-PP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
BB	BB	NN	B-NP	B-protein
,	,	,	O	O
ARB	ARB	NN	B-NP	B-protein
,	,	,	O	O
plavix	plavix	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
for	for	IN	B-PP	O
stroke	stroke	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CARDS	CARDS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
R	R	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
issues	issue	NNS	I-NP	O
with	with	IN	B-PP	O
rate	rate	NN	B-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DM	DM	NN	I-NP	O
:	:	:	O	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
lantus	lantus	NN	B-NP	O
48U	48U	NN	I-NP	O
qAM	qAM	NN	I-NP	O
with	with	IN	B-PP	O
novalog	novalog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
for	for	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

Added	Add	VBN	B-NP	O
3U	3U	NN	I-NP	O
novalog	novalog	NN	I-NP	O
before	before	IN	B-PP	O
each	each	DT	B-NP	O
meal	meal	NN	I-NP	O
.	.	.	O	O

HbA1C	HbA1C	NN	B-NP	O
acceptable	acceptable	JJ	I-NP	O
<	<	SYM	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CRI	CRI	NN	I-NP	O
:	:	:	O	O
stable	stable	JJ	B-NP	O
CRI	CRI	NN	I-NP	O
,	,	,	O	O
Cr	Cr	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
change	change	VB	I-VP	O
with	with	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
ARB	ARB	NN	I-NP	B-protein
,	,	,	O	O
nephrocaps	nephrocap	NNS	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
HEME	HEME	NN	I-NP	B-protein
:	:	:	O	O
picture	picture	NN	B-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
iron	iron	NN	B-NP	O
def	def	NN	I-NP	O
anemia	anemia	NN	I-NP	O
+	+	SYM	B-NP	O
anemia	anemia	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
TID	TID	NN	B-NP	O
iron	iron	NN	I-NP	O
and	and	CC	O	O
darbepoein	darbepoein	NN	B-NP	O
qWeek	qWeek	NN	I-NP	O
.	.	.	O	O

Discharge	Discharge	NNP	B-NP	O
Hct	Hct	NNP	I-NP	O
still	still	RB	B-ADVP	O
27	27	CD	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
UTI	UTI	NN	I-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
developed	develop	VBD	B-VP	O
foley	foley	NN	B-NP	O
related	relate	VBN	B-VP	O
UTI	UTI	NNP	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
grade	grade	NN	I-NP	O
temp	temp	NN	I-NP	O
and	and	CC	O	O
WBC	WBC	NN	B-NP	B-DNA
11	11	CD	I-NP	I-DNA
.	.	.	O	O

Pansenstive	Pansenstive	JJ	B-NP	O
Ecol	Ecol	NN	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
at	at	IN	B-PP	O
renal	renal	JJ	B-NP	O
dosing	dosing	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
10	10	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PT	PT	NN	I-NP	O
:	:	:	O	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
evaluated	evaluate	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
recommended	recommend	VBD	B-VP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
and	and	CC	O	O
home	home	NN	B-NP	O
PT	PT	NN	I-NP	O
assessment	assessment	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
FEN	FEN	NNP	I-NP	O
:	:	:	O	O
2g	2g	CD	B-NP	O
NA	NA	NN	I-NP	O
,	,	,	O	O
2L	2L	NN	B-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
,	,	,	O	O
ADA	ADA	NN	B-NP	B-protein
,	,	,	O	O
low	low	JJ	B-NP	O
fat	fat	NN	I-NP	O
diet	diet	NN	I-NP	O
11	11	CD	I-NP	O
-RRB-	-RRB-	:	O	O
PROPHY	PROPHY	NN	B-NP	O
:	:	:	O	O
heparin	heparin	NN	B-NP	O
12	12	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DISPO	DISPO	NN	I-NP	O
:	:	:	O	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
VNA	VNA	NN	I-NP	O
,	,	,	O	O
PT	PT	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
****************	****************	SYM	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Home	Home	NNP	I-NP	O
PT	PT	NNP	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
do	do	VBP	O	O
home	home	NN	B-NP	O
PT	PT	NN	I-NP	O
eval	eval	NN	I-NP	O
and	and	CC	O	O
assist	assist	NN	B-NP	O
with	with	IN	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
walker	walker	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
new	new	JJ	I-NP	O
device	device	NN	I-NP	O
for	for	IN	B-PP	O
him	him	PRP	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
VNA	VNA	NN	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
measure	measure	NN	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
weight	weight	NN	I-NP	O
and	and	CC	I-NP	O
BP	BP	NN	I-NP	O
and	and	CC	O	O
report	report	VB	B-VP	O
any	any	DT	B-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
over	over	IN	B-PP	O
3lbs	3lb	NNS	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
dry	dry	JJ	B-NP	O
weight	weight	NN	I-NP	O
240lbs	240lb	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
or	or	CC	I-NP	O
BP	BP	NN	I-NP	O
>	>	JJR	B-NP	O
140	140	CD	I-NP	O
or	or	CC	O	O
<	<	SYM	O	O
100	100	CD	B-NP	O
to	to	TO	B-PP	O
PCP	PCP	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Macaulay	Macaulay	NNP	I-NP	O
at	at	IN	B-PP	O
930.156.2543	930.156.2543	CD	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Mr.	Mr.	NNP	I-NP	O
Scipioni	Scipioni	NNP	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
eat	eat	VB	I-VP	O
more	more	JJR	B-NP	O
than	than	IN	B-PP	O
2g	2g	NN	B-NP	O
of	of	IN	B-PP	O
salt	salt	NN	B-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
or	or	CC	O	O
drink	drink	VB	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	B-PP	O
2L	2L	NN	B-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
eat	eat	VB	I-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
measure	measure	VB	I-VP	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
every	every	DT	B-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
goes	go	VBZ	B-VP	O
up	up	RP	B-PRT	O
by	by	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	B-PP	O
3lbs	3lb	NNS	B-NP	B-protein
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Mr.	Mr.	NNP	I-NP	O
Balfe	Balfe	NNP	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
note	note	VB	B-VP	O
your	your	PRP$	B-NP	O
new	new	JJ	I-NP	O
medications	medication	NNS	I-NP	O
are	be	VBP	B-VP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
for	for	IN	B-PP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
only	only	RB	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
,	,	,	O	O
iron	iron	NN	B-NP	O
,	,	,	O	O
darbepoetin	darbepoetin	NN	B-NP	O
shots	shot	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
HCTZ	HCTZ	NN	B-NP	B-protein
.	.	.	O	O

Your	Your	PRP$	B-NP	O
atenolol	atenolol	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stopped	stop	VBN	I-VP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
labetalol	labetalol	NN	I-NP	O
and	and	CC	I-NP	O
nifedipine	nifedipine	NN	I-NP	O
doses	dose	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
increased	increase	VBN	I-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
New	New	NNP	I-NP	O
meds	med	NNS	I-NP	O
are	be	VBP	B-VP	O
cipro	cipro	AFX	B-ADJP	O
-LRB-	-LRB-	HYPH	B-NP	B-protein
10	10	CD	I-NP	I-protein
day	day	NN	I-NP	I-protein
course	course	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
iron	iron	NN	B-NP	O
,	,	,	O	O
darbepoetin	darbepoetin	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
10/28	10/28	CD	B-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
see	see	VB	I-VP	O
you	you	PRP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
office	office	NN	I-NP	O
7/18	7/18	CD	I-NP	O
and	and	CC	O	O
you	you	PRP	B-NP	O
can	can	MD	B-VP	O
decide	decide	VB	I-VP	O
whether	whether	IN	B-SBAR	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
qWk	qWk	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
HCTZ	HCTZ	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	O
Meds	Med	NNS	I-NP	O
stopped	stop	VBD	B-VP	O
:	:	:	O	O
atenolol	atenolol	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
pt	pt	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
beta	beta	NN	I-NP	O
blockers	blocker	NNS	I-NP	O
-RRB-	-RRB-	SYM	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Meds	Med	NNS	I-NP	O
changed	change	VBD	B-VP	O
:	:	:	O	O
labetalol	labetalol	NN	B-VP	O
up	up	RP	B-PRT	O
titrated	titrate	VBN	B-VP	O
to	to	TO	B-PP	O
200mg	200mg	CD	B-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
nifedipine	nifedipine	NN	B-NP	O
up	up	RB	B-VP	O
titrated	titrate	VBN	I-VP	O
to	to	TO	B-PP	O
120mg	120mg	CD	B-NP	O
daily	daily	JJ	I-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Please	Please	NN	I-NP	O
uptitrate	uptitrate	VBP	B-VP	O
lasix	lasix	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-NP	O
No	No	DT	I-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
WHEATER	WHEATER	NNP	B-NP	O
,	,	,	O	O
NATHANIAL	NATHANIAL	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HV54	HV54	NN	I-NP	B-protein
-RRB-	-RRB-	NNP	B-NP	O
7/9/07	7/9/07	CD	I-NP	O
@	@	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
36	36	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

